To hear about similar clinical trials, please enter your email below
Trial Title:
Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer With Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial
NCT ID:
NCT06288854
Condition:
Weight Gain
Conditions: Official terms:
Body Weight
Weight Gain
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
olanzapine vs placebo
Primary purpose:
Prevention
Masking:
Single (Participant)
Intervention:
Intervention type:
Other
Intervention name:
weight gain each group
Description:
weight gain after 12 Weeks
Arm group label:
Olanzapine
Arm group label:
Placebo
Other name:
body weight
Summary:
- Efficacy of olanzapine on weight gain in advanced stage gynecologic cancer
- Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel
and carboplatin chemotherapy gain weight on olanzapine or placebo
Detailed description:
-Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and
carboplatin chemotherapy gain weight on olanzapine or placebo
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Advanced stage gynecologic cancer receiving Paclitaxel and carboplatin chemotherapy
- ECOG 0-1
- Normal CBC,Liver, renal function
- Communication in Thai language or Thai caregiver
- Inform consent
Exclusion Criteria:
- Pregnancy
- Active infection
- Bowel obstruction or history of bowel surgery
- On dopamine receptor antagonists or psychiatric or anticonvulsant medication
- Olanzapine allery
- Abnormal function of liver and renal
- Diabetic melitus or morbid obesity
- patient can't selfcare
Gender:
Female
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Rajavithi Hospital
Address:
City:
Bangkok
Country:
Thailand
Status:
Recruiting
Contact:
Last name:
Putsarat Insin
Phone:
022062900
Email:
ec.rajavithihospital@gmail.com
Start date:
April 3, 2024
Completion date:
June 30, 2025
Lead sponsor:
Agency:
Rajavithi Hospital
Agency class:
Other
Source:
Rajavithi Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06288854